Monteverde & Associates PC, a top-ranked class action law firm, is investigating Aethlon Medical's merger with North Immunology. The deal would give Aethlon shareholders about 4.75% ownership in the combined company. The firm is assessing whether the transaction is fair to shareholders and offers free consultations for those affected. This investigation could lead to legal action if shareholder interests are compromised.
The shareholder alert concerning Aethlon Medical, Inc. is presented here with context from the health sector on Pluang. For readers following health stocks, as of Sep 18, 2026 23:02 WIB, out of 92 priced US health-sector stocks on Pluang, 22 rose and 70 fell. Notable movers include Acadia Healthcare Company Inc (ACHC) at USD 28.25 with a 1-day change of -1.94%, GSK plc (GSK) at USD 50.08 with a 1-day change of -1.92% and 100% sell order activity, and Vertex Pharmaceuticals Incorporated (VRTX) at USD 506.54 with a 1-day change of -1.86% and 95% buy order activity.
Shares of TJGC Group Limited jumped nearly 54% after announcing plans to expand into AI hardware, led by new leadership in electronics manufacturing. Forward Industries rose 24% following an updated acquisition proposal for SkyAI, offering a 50% prem...
On Holding, a Swiss athletic shoe company, is expanding into the global football market by partnering with soccer star Kylian Mbappé, who leaves Nike after nearly 20 years. This marks On Holding's first venture into football cleats and apparel, lever...
Lument Finance Trust's Board of Directors has suspended the quarterly dividend on its common stock starting with the third quarter of 2026. This decision aims to preserve capital and maintain financial flexibility while still meeting REIT taxable inc...
Hybrid Power Solutions Inc., a Canadian clean energy company, has closed a non-brokered private placement raising CAD 617,500 by issuing 12.35 million units at CAD 0.05 each. Each unit includes one common share and one warrant exercisable at CAD 0.06...
Costco's new same-day delivery deal with DoorDash caused Instacart's stock to drop, but Instacart still powers Costco's branded sites and expanded internationally. The market reacted sharply, yet analysts remain optimistic with a $58 price target, ci...
